These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32068479)

  • 21. Superheroes - Image and performance enhancing drug (IPED) use within the UK, social media and gym culture.
    Richardson A; Dixon K; Kean J
    J Forensic Leg Med; 2019 May; 64():28-30. PubMed ID: 30921558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use.
    Hanley Santos G; Coomber R
    Int J Drug Policy; 2017 Feb; 40():35-43. PubMed ID: 27955960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and implementation of a community-based prevention programme targeting anabolic androgenic steroid use in gyms: study protocol of a quasi-experimental control group study.
    Molero Y; Gripenberg J; Bakshi AS
    BMC Sports Sci Med Rehabil; 2016; 8():36. PubMed ID: 27891233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of knowledge and beliefs on consumption of performance enhancing agents in north-western Saudi Arabia.
    Al OM; Elshatarat RA
    Ann Saudi Med; 2017; 37(4):317-325. PubMed ID: 28761032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Dietary Supplements in Fitness Practitioners: A Cross-Sectional Observation Study.
    Mazzilli M; Macaluso F; Zambelli S; Picerno P; Iuliano E
    Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34065071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities.
    Bojsen-Møller J; Christiansen AV
    Scand J Med Sci Sports; 2010 Dec; 20(6):861-7. PubMed ID: 19843266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and awareness of Anabolic Androgenic Steroids (AAS) among gymnasts in the western province of Riyadh, Saudi Arabia.
    Al Bishi KA; Afify A
    Electron Physician; 2017 Dec; 9(12):6050-6057. PubMed ID: 29560159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weightlifting's risky new trend: a case series of 41 insulin users.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Curr Sports Med Rep; 2012; 11(4):176-9. PubMed ID: 22777326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disability and the gym: experiences, barriers and facilitators of gym use for individuals with physical disabilities.
    Richardson EV; Smith B; Papathomas A
    Disabil Rehabil; 2017 Sep; 39(19):1950-1957. PubMed ID: 27626359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and Behaviors of Older Male Anabolic Steroid Users.
    Ip EJ; Trinh K; Tenerowicz MJ; Pal J; Lindfelt TA; Perry PJ
    J Pharm Pract; 2015 Oct; 28(5):450-6. PubMed ID: 24643452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Knowledge and attitude regarding use of anabolic steroids among youth exercising in fitness centers].
    Tamir E; Ner YZ; Dayan Y; Tamir D
    Harefuah; 2004 May; 143(5):348-52, 391. PubMed ID: 15190846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anabolic-Androgenic Steroids and Prohibited Substances Misuse among Iranian Recreational Female Bodybuilders and its Associated Psycho-socio-demographic Factors.
    Angoorani H; Jalali M; Halabchi F
    Addict Health; 2018 Oct; 10(4):216-222. PubMed ID: 31263520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased atherothrombotic markers and endothelial dysfunction in steroid users.
    Severo CB; Ribeiro JP; Umpierre D; Da Silveira AD; Padilha MC; De Aquino Neto FR; Stein R
    Eur J Prev Cardiol; 2013 Apr; 20(2):195-201. PubMed ID: 22345686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
    McDuff D; Stull T; Castaldelli-Maia JM; Hitchcock ME; Hainline B; Reardon CL
    Br J Sports Med; 2019 Jun; 53(12):754-760. PubMed ID: 31097457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious disease, injection practices, and risky sexual behavior among anabolic steroid users.
    Ip EJ; Yadao MA; Shah BM; Lau B
    AIDS Care; 2016; 28(3):294-9. PubMed ID: 26422090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of outdoor gym use: Current evidence and future directions.
    Jansson AK; Lubans DR; Smith JJ; Duncan MJ; Haslam R; Plotnikoff RC
    J Sci Med Sport; 2019 Dec; 22(12):1335-1343. PubMed ID: 31444034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology of doping in rural gyms in the district of Traunstein].
    Raschka C; Draßner N
    MMW Fortschr Med; 2015 Jul; 157 Suppl 5():5-8. PubMed ID: 26168742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and profile of users and non-users of anabolic steroids among resistance training practitioners.
    Pereira E; Moyses SJ; Ignácio SA; Mendes DK; Silva DSDA; Carneiro E; Hardy AMTG; Rosa EAR; Bettega PVC; Johann ACBR
    BMC Public Health; 2019 Dec; 19(1):1650. PubMed ID: 31818274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge, attitudes and practices of anabolic steroid usage among gym users in Trinidad.
    Maharaj VR; Dookie T; Mohammed S; Ince S; Marsang BL; Rambocas N; Chin M; McDougall L; Teelucksingh S
    West Indian Med J; 2000 Mar; 49(1):55-8. PubMed ID: 10786454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.